ABSTRACT OF THE WEEK

Comparative immunology, microbiology and infectious diseases
Volume 83 | Issue 0 (April 2022)

Xanthinuria secondary to allopurinol treatment in dogs with leishmaniosis: Current perspectives of the Iberian veterinary community.

Comp Immunol Microbiol Infect Dis. April 2022;83(0):101783.

Laura Jesus¹, Carolina Arenas², Marina Domínguez-Ruiz³, Paolo Silvestrini⁴, Ryane E Englar⁵, Xavier Roura⁶, Rodolfo Oliveira Leal⁷

¹ Hospital Escolar Veterinário - Faculty of Veterinary Medicine, University of Lisbon, Lisbon, Portugal.; ² Hospital Veterinario Anicura Valencia Sur, Valencia, Spain.; ³ Hospital Clínico Veterinario, Universidad Alfonso X el Sabio (UAX), Madrid, Spain.; ⁴ Ryan Veterinary Hospital - PennVet, University of Pennsylvania, USA.; ⁵ College of Veterinary Medicine, University of Arizona, Oro Valley, AZ 85737, USA.; ⁶ Hospital Clínic Veterinari, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.; ⁷ Hospital Escolar Veterinário - Faculty of Veterinary Medicine, University of Lisbon, Lisbon, Portugal; CIISA - Centro de Investigação Interdisciplinar em Sanidade Animal, Faculdade de Medicina Veterinária, Universidade de Lisboa, Portugal. Electronic address: rleal@fmv.ulisboa.pt.

Abstract

Xanthinuria is a significant adverse effect in dogs on long-term allopurinol for treatment of leishmaniosis. The study aims to investigate how the Iberian veterinary community (IVC) identifies, manages, and proactively prevents xanthinuria secondary to allopurinol treatment. A cross-sectional study was conducted using an online survey, translated into two languages, and disseminated to the IVC via social networking forums. Respondents were asked to share their treatment regimens, adverse effects attributed to treatment, as well as preventive and reactive measures against xanthuria. Of two-hundred and thirty respondents, 99.6% prescribe allopurinol for canine leishmaniosis. Xanthinuria was estimated to happen in less than one out of every four dogs by 91.7% of the clinicians. Xanthinuria has been detected by 71.6% of respondents at least once. Three out of every four respondents inform owners about deleterious effects of allopurinol, and 28.4% consider implementing a change in diet in advance of treatment as a proactive measure. To monitor xanthinuria, urinalysis and diagnostic imaging are used by 71.2% and 31% of clinicians respectively. When xanthinuria is detected, 43.2% of the respondents discontinue allopurinol, 24% replace it by nucleotide-analogs, 14.9% reduce its dosage, and 3.1% split its dosage but increase administration frequency. Additional measures are taken by 72.1% of the respondents, 59.4% of whom prescribe a low-purine diet. The IVC recognizes xanthinuria as a fairly common secondary effect of long-term allopurinol treatment in dogs with leishmaniosis and recommends periodically monitoring and preventive measures.

Companion Notes

Survey of the Iberian veterinary community on xanthinuria secondary to allopurinol treatment in dogs with leishmaniosis

Introduction on xanthinuria

- common adverse effect in dogs with leishmaniosis being treated with allopurinol

Study design

- study population: Iberian veterinary community

- procedure:

- online anonymous survey placed online after internal validation

- clinician informed about survey via Iberic social network veterinary groups

Results:230 responses obtained: 131 from Portugal and 99 from Spain

- 99.6% (229/230) of clinicians use allopurinol as part of CanLeish treatment

(CanLeish = canine leishmaniosis)

- 71.6% (164/229) have identified xanthinuria in dogs with leishmaniosis

(at least once)

- 91.7% estimated xanthinuria occurred in less than 1 out of every 4 dogs

- 78.7% (129/164) generally diagnose xanthinuria based on detection of crystalluria

- 12.2% by post-removal urolith analysis

- 5.5% on detection of urolithiasis on abdominal ultrasonography

- reported complications associated with xanthinuria included the following:

- urinary clinical signs (dysuria, stranguria, pollakiuria), 68.8% (110/160)

- non-obstructive urolithiasis, 59.4%

- renal mineralization, 37.5%

- bacterial cystitis, 31.3%

- urethral obstruction, 29.4%

- ureteral obstruction, 17.5%

- xanthinuria prevention

- 75.1% (172/229) inform clients of the adverse effects of allopurinol

- 28.4% consider a change to low purine diet

- monitoring of urinary adverse effects

- urinalysis prioritized, 71.2% (163/229)

- diagnostic imaging prioritized, 31% (71/229)

- abdominal ultrasonography preferred, 94.4% (67/71)

- survey abdominal radiography, 5.6%

- steps taken when xanthinuria develops

- 43.2% (99/229) stop allopurinol treatment

- 24% switch for AHCC associated with nucleotides

(AHCC = active hexose correlated compound)

- 17.9% change frequency or dosage of allopurinol administration

- 14.9% reduce dosage

- 3.1% split the dosage but increase administration frequency

- 5.2% stay with same therapy

- additional steps taken when xanthinuria develops, 72.1%

- dietary modification (low purine diet), 59.4% (98/165)

- stimulate water intake, 15.2%

- increase frequency of clinical monitoring, 15.2%

- other, 5.5%

- increase wet food consumption, 4.9%

“Although preventive measures are often neglected, clinicians seem to be conscious about the options to manage xanthinuria in dogs with leishmaniosis, under allopurinol treatment.”

Keywords

Canine; Kidney; Leishmania; Portugal; Spain; Urolithiasis; Xanthine;

Article Tools:

Medline

Email to me

Archives Highlights:

Clinical characterization of a novel episodic ataxia in young working Cocker Spaniels.
The mean age at clinical onset was 4 months. Signs were acute and included episodic body swaying, titubation, cerebellar ataxia, wide-base stance, and hypermetria, all while mentation remained unaltered. Duration of episodes ranged from 30 minutes up to 24 hours, and their frequency varied from weekly to once every 5 months.

Prevalence of elbow dysplasia in 13 dog breeds in France: a retrospective radiographic study (2002-2022).
The overall prevalence of ED was 11.4%, ranging from 1.1% in the Czechoslovakian Wolfdog to 32.2% in the Dogue de Bordeaux. The Dogue de Bordeaux, Rottweiler, Bernese Mountain Dog, and Cane Corso breeds were most commonly affected by ED. The prevalence of ED was significantly higher in male dogs than in female dogs (17.5% vs 10.5%). Joint incongruity and fragmented coronoid process were the 2 most common primary ED lesions identified.

Trust in veterinarians and association with vaccine information sources and vaccination status among dog and cat owners.
62.9% of dog and 61.2% of cat owners were classified as trusting their veterinarians. On average, dog owners consulted 2.50 sources about vaccine information; cat owners consulted 2.27 sources. Veterinarians were the most common primary sources of information for 85.4% of dog owners with high levels of trust, but only 62.6% of dog owners with lower levels. This was the case for 83.8% and 56.3% of cat owners.

Retrospective cohort study on diseases and risk factors associated with death in hospitalized neonatal foals.
Most prevalent diseases were sepsis (43.9%), enteritis (14.0%), and omphalitis (9.0%). Case fatality rate was 33.3%. Neonatal sepsis significantly increased the risk of death.

Clinical manifestations of chronic pancreatitis in English cocker spaniels.
Affected English cocker spaniels presented with a high frequency of KCS (n = 49), proteinuria (n = 47), anal gland disease (n = 36), atopy (n = 21), and other immune-mediated diseases (n = 16). Those with parti-color hair coats, particularly blue roan, had a strong association with chronic pancreatitis, suggesting a link between coat color and autoimmune conditions in this breed.